Hydrocortisone acetate; oxytetracycline hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrocortisone acetate; oxytetracycline hydrochloride and what is the scope of freedom to operate?
Hydrocortisone acetate; oxytetracycline hydrochloride
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for hydrocortisone acetate; oxytetracycline hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | hydrocortisone acetate; oxytetracycline hydrochloride at DailyMed |
Recent Clinical Trials for hydrocortisone acetate; oxytetracycline hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
See all hydrocortisone acetate; oxytetracycline hydrochloride clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for hydrocortisone acetate; oxytetracycline hydrochloride
US Patents and Regulatory Information for hydrocortisone acetate; oxytetracycline hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | TERRA-CORTRIL | hydrocortisone acetate; oxytetracycline hydrochloride | SUSPENSION;OPHTHALMIC | 061016-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |